Background: Both fractional flow reserve (FFR)-guided and intravascular ultrasound (IVUS)-guided strategies have been reported to safe and effective in coronary lesions. However, we are clinically in a dilemma between IVUS-minimum lumen area (MLA)≤4.0mm 2 and FFR>0.80 (defined as "Mismatch diseases") in severe coronary artery stenosis (defined as 75% to 90% diameter stenosis by visual assessment), especially in non-LAD lesions. Method: FFR and IVUS measurements were performed in 122 lesions (LAD: 66 lesions and non-LAD: 56 lesions) of severe coronary stenosis (95 stable patients) that located at the proximal or mid part of major coronary artery. Acute coronary syndrome, LMT lesions, tandem lesions, and CABG cases were excluded. The FFR value was checked after intracoronary administration of papaverin to induce maximal hyperemia. We divided into LAD and non-LAD lesions and compared a prevalence of mismatch diseases in LAD lesions and that in non-LAD lesions. The ROC analysis was performed to evaluate IVUS-MLA for estimating FFR≤0.80 in each lesions. Result: A prevalence of mismatch diseases in non-LAD lesions was significantly higher than that in LAD lesions (LAD vs 
Background: Vascular Smooth Muscle Cell (VSMC) proliferation is of importance in the pathogenesis of vascular diseases such as restenosis or atherosclerosis. Endothelial Microparticles (EMP) have been shown to promote vascular regenration by transferring functional microRNAs, but whether they influence VSMC biology is largely unknown. We explored the influence of EMP on neointima formation in a model of acute vascular injury in vivo and on VSMC proliferation and migration in vitro. Methods and results: After wire injury of the carotid artery, mice were treated systemically with EMP generated from Human Coronary Artery Endothelial Cells (HCAEC). Mice treated with EMP showed a significantly reduced neointimal formation (0.63±0.03 vs. 0.47±0.04,p<0.05, n=8). Furthermore, VSMCs treated with EMPs showed significantly reduced proliferation and migration capacities, both critical steps in neointimaformation (p<0.05 after 6h, p<0.01 after 8 h, n=7-8). Following experiments revealed a time dependent uptake of EMP into VSMCs in vitro. In order to dissect the underlying mechanisms, Taqman microRNA-array was performed and microRNA (miR)-126 was identified as the predominantly expressed miR in EMP. Furthermore, miR-126 was transported into recipient VSMC by EMP (1±0.05 vs. 1.34±0.05, p<0.05). Interestingly, expression of the target protein LRP6, regulating VSMC proliferation, was altered in VSMCs after EMP treatment. Conclusions: Endothelial microparticles reduce neointimal formation in a model of acute arterial injury in vivo and decrease proliferation and migration of vascular smooth muscle cells in vitro. The transfer of mir126 by EMP and subsequent regulation of LRP6 expression in VSMCs might be a possible pathway. Purpose: Ubiquitous reduction of the gap junction protein connexin43 (Cx43) in mice provides beneficial effects on progression and composition of atherosclerotic lesions. Cx43 is expressed in multiple atheroma-associated cells, such as endothelial cells, smooth muscle cells and macrophages, but the exact contribution of Cx43 in each cell type during atherogenesis is not known.
| BENCH

Methods and results:
To examine specifically the role of Cx43 in immune cells, low-density lipoprotein receptor-deficient mice were lethally irradiated and reconstituted with Cx43+/+, Cx43+/-or Cx43-/-hematopoietic fetal liver cells. Five weeks after reconstitution, mice received a cholesterol-rich diet (HCD) for 14 weeks. The three groups displayed similar increases in body weight and serum cholesterol after HCD. The progression of atherosclerosis (% lipid deposition) was significantly lower in aortic roots of Cx43+/-chimeras (11.4±1.0%; N=8; P<0.01) compared with Cx43+/+ (16.3±1.9%) and Cx43-/-(17.9±1.0%) chimeras. Plaque composition was comparable in the 3 groups for macrophages (CD68), T lymphocytes (CD4) and extracellular matrix (Masson Trichrome, Picosirius Red), but Cx43+/-chimera's plaques contained significantly less neutrophils (Ly6G-positive area; 1.9±0.7%; N=8; P<0.05) compared with Cx43+/+ (6.0±1.6%) and Cx43-/-(6.5±1.4%) chimera's plaques. Surprisingly, neutrophils obtained from peripheral blood of control and hypercholesterolemic mice did not express Cx43. Functional tests for neutrophils (in vitro endothelial adhesion assay and in vivo alveolar transmigration assay) showed no difference between neutrophils from Cx43+/+ and Cx43+/-mice. Finally, we observed less proliferating cells in bone marrow of Cx43+/-chimeras in comparison to Cx43+/+ and Cx43-/-chimeras, but the relative proportions of circulating neutrophils, lymphocytes and monocytes were similar between the 3 groups. Conclusion: Our study shows that reduction of Cx43 expression in immune cells reduces atherosclerotic plaque formation and infiltration of neutrophils into the lesion, whereas deletion of Cx43 from immune cells abrogates this protective effect. As neutrophils are devoid of Cx43, our results warrant further studies towards a possible differential secretion of chemoattractant molecules by other Cx43-expressing immune cells such as macrophages.
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Poly(ADP-ribose) polymerase -14 interacts with tristetraprolin to selectively regulate tissue factor mRNA stability: a novel role for ADP-ribosylation in regulating mRNA turnover and thrombosis
